GMU inaugurates Thumbay Institute of Clinical Simulation

IMT News Desk
IMT News Desk
· 2 min read

The facilities will standardise skills training across disciplines and raise the bar for patient safety across the region

Gulf Medical University has opened the Thumbay Institute of Clinical Simulation at its Ajman campus, a next-generation training hub designed to let students, residents, and practicing clinicians learn, rehearse, and master real-world care in a safe, high-fidelity environment.

The new institute delivers team-based drills, Objective Structured Clinical Examinations (OSCEs), crisis resource management, and procedure training across medicine and allied health—using advanced manikins, task trainers, simulated wards, and digital recording for debrief.

The network includes:

1. Thumbay Clinical Simulation Centre

2. Dental Simulation Centre

3. Physiotherapy Simulation Centre

4. Thumbay Surgical Skills Center

5. Upcoming Thumbay Veterinary Simulation Centre (small and large animals)

6. Upcoming Thumbay Simulation Centre in Dubai

Together, these facilities will standardise skills training across disciplines and raise the bar for patient safety across the region.

Prof Manda Venkatramana, Chancellor of Gulf Medical University, said, “Simulation changes outcomes. It lets our learners make mistakes without harm, learn as teams, and return to the bedside more confident and more prepared. With this institute and our growing network across medicine, dentistry, physiotherapy, surgery, and soon veterinary medicine, GMU is setting a national standard for hands-on health-professions education.”

The facility features simulation suites replicating ICU, emergency, operating theatre, primary care, inpatient wards, and home-care settings. Every session is recorded for structured debrief so learners can see, measure, and improve performance. The curriculum spans communication, ethics, cultural competence, and leadership under pressure, not just procedures and protocols.

Memberships, Accreditations & Affiliations:

· American Heart Association (AHA) International Training Centre

· National Association of Emergency Medical Technicians (NAEMT)

· Society in Europe for Simulation Applied to Medicine (SESAM)

· Membership of the Royal College of Physicians of the United Kingdom MRCP (UK)

· (Jaheziya) Emirates Medical Preparedness and Response Program

· Health and Safety Institute (HSI)

Read Next

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences
Global News
January 20, 2026

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences

To advance BOT+BAL and strengthen US manufacturing readiness Agenus, a leader in immuno-oncology innovation, announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is designed to accelerate global development and potential commercialisation of Agenus’ botensilimab and balstilimab (BOT+BAL) immunotherapy combination programme. The collaboration provides Agenus with strategic capital and […]
Article by: IMT News Desk
Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia
Global News
January 16, 2026

Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia

Approval marks Venus Remedies’ first anti-infective marketing authorisation in Indonesia and enables the country’s first generic entry for this critical antibiotic combination Venus Remedies has secured the marketing authorisation from the Indonesian regulatory authority for its combination antibiotic, Ceftazidime + Avibactam. This approval represents Venus Remedies’ first marketing authorization in the anti-infective segment in Indonesia […]
Article by: IMT News Desk
Wegovy pill approved in the US for weight management
Global News
December 26, 2025

Wegovy pill approved in the US for weight management

Novo Nordisk expects to launch the Wegovy pill in the US in early January 2026 Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse […]
Article by: IMT News Desk
Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK
Global News
December 24, 2025

Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK

Under the terms of the agreement, with closing anticipated toward the end of Q1 of 2026, Samsung Biologics will acquire the Rockville assets for $280 million Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100 […]
Article by: IMT News Desk